Ray continued, “We’re also delighted to recognize Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology were instrumental to shaping the development of STK-012, our initial-in-course alpha/beta biased IL-two. Its unique mechanism expands the therapeutic index of IL-2, certainly one of https://https-www-zosanopharma-co85038.tokka-blog.com/36941038/little-known-facts-about-https-www-zosanopharma-com-technology